乐普医疗
(300003)
| 流通市值：218.66亿 | | | 总市值：254.45亿 |
| 流通股本：16.16亿 | | | 总股本：18.81亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 6,259,227,849.28 | 4,301,457,705.65 | 2,437,202,386.92 | 10,609,442,080.61 |
| 营业收入 | 6,259,227,849.28 | 4,301,457,705.65 | 2,437,202,386.92 | 10,609,442,080.61 |
| 二、营业总成本 | 4,727,014,426.22 | 3,214,116,746.52 | 1,749,019,988.44 | 7,926,747,100.31 |
| 营业成本 | 2,184,268,805.05 | 1,509,970,638.81 | 805,474,394.75 | 3,983,285,816.15 |
| 税金及附加 | 66,174,243.53 | 45,754,564.21 | 24,992,941.86 | 117,466,953.94 |
| 销售费用 | 1,193,544,744.18 | 803,746,164.81 | 440,814,329.67 | 2,033,685,507.32 |
| 管理费用 | 564,543,747.14 | 377,645,539.43 | 193,623,961.57 | 742,669,161.21 |
| 研发费用 | 674,829,181.31 | 441,219,153.24 | 229,686,257.3 | 957,062,067.79 |
| 财务费用 | 43,653,705.01 | 35,780,686.02 | 54,428,103.29 | 92,577,593.9 |
| 其中:利息费用 | 124,508,597.81 | 86,972,386.71 | 43,468,101.66 | 188,775,142.07 |
| 其中:利息收入 | 88,974,288.07 | 62,718,389.82 | 34,161,881.52 | 87,989,301.57 |
| 加:公允价值变动收益 | 4,017,391.6 | 16,271,677.41 | 5,759,598.45 | 4,420,275.05 |
| 加:投资收益 | -40,933,488.02 | -23,036,741.79 | -21,542,984.71 | -75,334,941.16 |
| 资产处置收益 | -1,488,369.54 | 1,253,000.35 | 1,253,000.35 | 24,271.66 |
| 资产减值损失(新) | -6,097,593.05 | -1,938,876.67 | 877,615.53 | -37,952,811.58 |
| 信用减值损失(新) | -21,516,916.12 | -17,866,091.94 | -440,479.31 | -34,280,115.19 |
| 其他收益 | 65,288,597.24 | 51,668,935.03 | 25,753,889.4 | 83,567,038.34 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,531,483,045.17 | 1,113,692,861.52 | 699,843,038.19 | 2,623,138,697.42 |
| 加:营业外收入 | 48,046,821.07 | 36,037,091.92 | 33,162,344.03 | 14,130,594.23 |
| 减:营业外支出 | 6,639,797.09 | 3,887,589.22 | 2,046,253.57 | 25,487,685.3 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,572,890,069.15 | 1,145,842,364.22 | 730,959,128.65 | 2,611,781,606.35 |
| 减:所得税费用 | 169,663,705.13 | 147,834,970.11 | 112,640,660.86 | 367,094,359.34 |
| 六、净利润 | 1,403,226,364.02 | 998,007,394.11 | 618,318,467.79 | 2,244,687,247.01 |
| 持续经营净利润 | 1,403,226,364.02 | 998,007,394.11 | 618,318,467.79 | 2,244,687,247.01 |
| 归属于母公司股东的净利润 | 1,353,600,791.72 | 961,487,273.99 | 596,924,222.49 | 2,202,809,390.54 |
| 少数股东损益 | 49,625,572.3 | 36,520,120.12 | 21,394,245.3 | 41,877,856.47 |
| (一)基本每股收益 | 0.73 | 0.52 | 0.32 | 1.22 |
| (二)稀释每股收益 | 0.73 | 0.51 | 0.32 | 1.21 |
| 八、其他综合收益 | 66,172,162.22 | 54,203,488.44 | 38,892,944.33 | -403,722,885.2 |
| 归属于母公司股东的其他综合收益 | 80,156,115 | 66,337,058.49 | 41,769,312.15 | -386,236,335.41 |
| 九、综合收益总额 | 1,469,398,526.24 | 1,052,210,882.55 | 657,211,412.12 | 1,840,964,361.81 |
| 归属于母公司股东的综合收益总额 | 1,433,756,906.72 | 1,027,824,332.48 | 638,693,534.64 | 1,816,573,055.13 |
| 归属于少数股东的综合收益总额 | 35,641,619.52 | 24,386,550.07 | 18,517,877.48 | 24,391,306.68 |
| 公告日期 | 2023-10-26 | 2023-08-26 | 2023-04-26 | 2023-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |